Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 9th May 2024 CHRS stock ended at $2.12. This is 4.93% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.35% from a day low at $2.11 to a day high of $2.27.
90 days $1.91 $2.87
52 weeks $1.44 $5.91

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Nov 25, 2016 $28.25 $28.40 $27.70 $28.05 199 367
Nov 23, 2016 $26.95 $28.30 $26.75 $28.10 318 877
Nov 22, 2016 $28.50 $28.55 $27.58 $27.75 227 903
Nov 21, 2016 $28.40 $28.69 $28.02 $28.45 265 398
Nov 18, 2016 $28.15 $28.60 $27.95 $28.25 300 303
Nov 17, 2016 $27.80 $28.25 $27.50 $28.00 302 395
Nov 16, 2016 $28.55 $28.95 $27.65 $27.70 264 595
Nov 15, 2016 $27.65 $28.95 $27.15 $28.50 385 054
Nov 14, 2016 $28.00 $28.35 $26.40 $28.05 779 012
Nov 11, 2016 $28.00 $28.20 $26.65 $27.65 485 574
Nov 10, 2016 $26.25 $29.55 $23.25 $27.95 1 091 202
Nov 09, 2016 $24.00 $27.35 $23.00 $27.10 727 746
Nov 08, 2016 $24.65 $25.60 $23.55 $24.15 881 135
Nov 07, 2016 $29.10 $29.40 $22.93 $25.60 2 409 700
Nov 04, 2016 $27.30 $29.20 $26.61 $28.15 270 500
Nov 03, 2016 $29.05 $29.35 $27.20 $27.30 386 800
Nov 02, 2016 $27.70 $29.60 $26.35 $29.05 380 200
Nov 01, 2016 $27.50 $28.50 $27.00 $27.80 279 200
Oct 31, 2016 $28.55 $28.63 $26.95 $27.35 382 400
Oct 28, 2016 $29.07 $30.44 $28.62 $28.70 355 300
Oct 27, 2016 $29.80 $30.43 $29.30 $29.50 271 900
Oct 26, 2016 $30.40 $31.05 $29.58 $29.73 286 800
Oct 25, 2016 $30.77 $31.32 $30.12 $30.52 297 400
Oct 24, 2016 $30.68 $31.48 $30.59 $30.69 189 500
Oct 21, 2016 $30.29 $31.10 $29.93 $30.49 296 100
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT